Bicara Therapeutics Inc. BCAX
19.21
(0.57)
(2.88%)
as of 25 Sep
- Market cap
- $1.3B
- P/E
- 0.0×
Follow BCAX
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | |
|---|---|---|---|
Current Ratio |
14.58 | 27.93 | 15.32 |
Net Debt/EBITDA |
2.67 | 5.95 | 5.78 |
Debt/Assets |
0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | — |
Operating CF/Net income |
0.77 | 1.10 | 0.88 |
Capex/Depreciation |
(0.69) | (0.16) | (30.84) |
Interest Coverage |
0.00 | 0.00 | 0.00 |
| (30.88%) | (39.63%) | 0.00% | |
| (29.32%) | (18.28%) | 0.00% | |
ROIC |
0.00% | (2,379.53%) | 0.00% |
Return on Tangible Assets |
(35.06%) | (14.03%) | (24.05%) |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(1.96) | (4.45) | (79.67) |
Cash per Share |
7.59 | 29.14 | 397.24 |
Shareholders Equity per Share |
7.34 | 29.27 | (256.45) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
7.34 | 29.27 | (256.45) |
Free Cash Flow |
(107.11) | (74.76) | (46.21) |
Working Capital |
393.10 | 484.54 | 215.99 |
Capital Expenditures |
(0.28) | (0.01) | (0.59) |
Net Current Asset Value |
392.51 | 484.41 | (151.68) |
| Other line items | |||
Quick Ratio |
14.33 | 27.22 | 15.28 |
Depreciation/Fixed assets |
1.23 | 0.36 | 0.09 |
Cash ROIC |
(13.13%) | (7.63%) | (56.12%) |
Accounts Payable Turnover |
0.00 | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 |
Operating CF per Share |
(1.95) | (4.45) | (78.66) |
Capex per Share |
(0.01) | 0.00 | (1.01) |
Average Payables |
4.70 | 3.02 | — |
Average Assets |
470.50 | 371.99 | — |
Average Common Equity |
446.66 | 171.55 | — |
Capex to Sales |
0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% |
Columns are period end dates